Annual SG&A
$92.69 M
+$24.77 M+36.48%
31 December 2023
Summary:
Cytek Biosciences annual selling, general & administrative expenses is currently $92.69 million, with the most recent change of +$24.77 million (+36.48%) on 31 December 2023. During the last 3 years, it has risen by +$68.34 million (+280.55%). CTKB annual SG&A is now at all-time high.CTKB Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$23.37 M
-$591.00 K-2.47%
30 September 2024
Summary:
Cytek Biosciences quarterly selling, general & administrative expenses is currently $23.37 million, with the most recent change of -$591.00 thousand (-2.47%) on 30 September 2024. Over the past year, it has increased by +$944.00 thousand (+4.21%). CTKB quarterly SG&A is now -7.08% below its all-time high of $25.15 million, reached on 30 June 2023.CTKB Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$155.15 M
-$10.16 M-7.01%
30 September 2024
Summary:
Cytek Biosciences TTM selling, general & administrative expenses is currently -$155.15 million, with the most recent change of -$10.16 million (-7.01%) on 30 September 2024. Over the past year, it has dropped by -$245.50 million (-271.72%). CTKB TTM SG&A is now -586.27% below its all-time high of $93.85 million, reached on 31 March 2024.CTKB TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTKB Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.5% | +4.2% | -271.7% |
| 3 y3 years | +280.6% | +90.0% | -513.8% |
| 5 y5 years | - | - | - |
CTKB Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +280.6% | -7.1% | +90.0% | -95.2% | at low |
| 5 y | 5 years | at high | +445.9% | -7.1% | +322.7% | -586.3% | at low |
| alltime | all time | at high | +445.9% | -7.1% | +322.7% | -586.3% | at low |
Cytek Biosciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $23.37 M(-2.5%) | $93.60 M(+1.0%) |
| June 2024 | - | $23.96 M(+0.0%) | $92.66 M(-1.3%) |
| Mar 2024 | - | $23.95 M(+7.3%) | $93.85 M(+0.8%) |
| Dec 2023 | $92.69 M(+36.5%) | $22.32 M(-0.5%) | $93.12 M(+3.1%) |
| Sept 2023 | - | $22.43 M(-10.8%) | $90.35 M(+6.6%) |
| June 2023 | - | $25.15 M(+8.3%) | $84.77 M(+10.6%) |
| Mar 2023 | - | $23.23 M(+18.8%) | $76.64 M(+12.8%) |
| Dec 2022 | $67.92 M | $19.54 M(+16.0%) | $67.92 M(+6.8%) |
| Sept 2022 | - | $16.85 M(-1.0%) | $63.62 M(+7.7%) |
| June 2022 | - | $17.02 M(+17.3%) | $59.07 M(+14.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $14.51 M(-4.8%) | $51.79 M(+13.7%) |
| Dec 2021 | $45.55 M(+87.0%) | $15.24 M(+23.9%) | $45.55 M(+21.5%) |
| Sept 2021 | - | $12.30 M(+26.3%) | $37.49 M(+22.0%) |
| June 2021 | - | $9.74 M(+17.9%) | $30.72 M(+15.7%) |
| Mar 2021 | - | $8.26 M(+14.9%) | $26.55 M(+9.0%) |
| Dec 2020 | $24.36 M(+43.5%) | $7.19 M(+30.0%) | $24.36 M(+41.9%) |
| Sept 2020 | - | $5.53 M(-0.8%) | $17.17 M(+47.5%) |
| June 2020 | - | $5.57 M(-8.2%) | $11.64 M(+91.8%) |
| Mar 2020 | - | $6.07 M | $6.07 M |
| Dec 2019 | $16.98 M | - | - |
FAQ
- What is Cytek Biosciences annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Cytek Biosciences?
- What is Cytek Biosciences annual SG&A year-on-year change?
- What is Cytek Biosciences quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Cytek Biosciences?
- What is Cytek Biosciences quarterly SG&A year-on-year change?
- What is Cytek Biosciences TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Cytek Biosciences?
- What is Cytek Biosciences TTM SG&A year-on-year change?
What is Cytek Biosciences annual selling, general & administrative expenses?
The current annual SG&A of CTKB is $92.69 M
What is the all time high annual SG&A for Cytek Biosciences?
Cytek Biosciences all-time high annual selling, general & administrative expenses is $92.69 M
What is Cytek Biosciences annual SG&A year-on-year change?
Over the past year, CTKB annual selling, general & administrative expenses has changed by +$24.77 M (+36.48%)
What is Cytek Biosciences quarterly selling, general & administrative expenses?
The current quarterly SG&A of CTKB is $23.37 M
What is the all time high quarterly SG&A for Cytek Biosciences?
Cytek Biosciences all-time high quarterly selling, general & administrative expenses is $25.15 M
What is Cytek Biosciences quarterly SG&A year-on-year change?
Over the past year, CTKB quarterly selling, general & administrative expenses has changed by +$944.00 K (+4.21%)
What is Cytek Biosciences TTM selling, general & administrative expenses?
The current TTM SG&A of CTKB is -$155.15 M
What is the all time high TTM SG&A for Cytek Biosciences?
Cytek Biosciences all-time high TTM selling, general & administrative expenses is $93.85 M
What is Cytek Biosciences TTM SG&A year-on-year change?
Over the past year, CTKB TTM selling, general & administrative expenses has changed by -$245.50 M (-271.72%)